Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00098709 · ClinicalTrials.gov registry record · Phase 3
Fetal Pulse Oximetry Trial (FOX)
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 10,000
- Enrollment target
NCT00098709 is a Phase 3 study that was terminated before completion, run by The George Washington University Biostatistics Center. The registered enrollment target is 10,000 participants.
The verdict
NCT00098709, a Phase 3 study, was terminated before completion, sponsored by The George Washington University Biostatistics Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 10,000 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the information provided to the physician by a fetal pulse oximeter during labor will reduce the chances of a cesarean delivery.
Interventions
- DEVICE Fetal pulse oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2002-05 |
| Est. Completion | 2005-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00098709
The ClinicalTrials.gov registry entry for NCT00098709 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fetal pulse oximeter is the first listed.
NCT00098709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00098709 about?
NCT00098709 is a clinical study titled "Fetal Pulse Oximetry Trial (FOX)". The purpose of this study is to determine if the information provided to the physician by a fetal pulse oximeter during labor will reduce the chances of a cesarean delivery.
What is the current status of trial NCT00098709?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 10,000 participants. The study started on 2002-05. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00098709?
The interventions under investigation include: Fetal pulse oximeter (DEVICE).
Who is sponsoring clinical trial NCT00098709?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.